Elevated high-sensitivity C-reactive protein (hsCRP) increases the risk of cardiovascular disease (CVD) in the general population, but its role as a predictive marker in HIV-positive patients remains unclear. Aim of the study was to evaluate whether hsCRP or other biomarkers are independent predictors of CVD risk in HIV-infected patients.
De Luca, A., De Gaetano Donati, K., Colafigli, M., Cozzi Lepri, A., De Curtis, A., Gori, A., Sighinolfi, L., Giacometti, A., Capobianchi, M., D'Avino, A., Iacoviello, L., Cauda, R., D'Arminio Monforte, A., The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study, <<BMC INFECTIOUS DISEASES>>, 2013; 13 (Settembre): 414-414. [doi:10.1186/1471-2334-13-414] [http://hdl.handle.net/10807/52365]
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study
De Luca, Andrea;De Gaetano Donati, Katleen;Colafigli, Manuela;D'Avino, Alessandro;Cauda, Roberto;
2013
Abstract
Elevated high-sensitivity C-reactive protein (hsCRP) increases the risk of cardiovascular disease (CVD) in the general population, but its role as a predictive marker in HIV-positive patients remains unclear. Aim of the study was to evaluate whether hsCRP or other biomarkers are independent predictors of CVD risk in HIV-infected patients.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
